Gastric Burkitt lymphoma associated with Efalizumab and Helicobacter pylori.
Faltas
Bishoy
B
Kramer
Zachary B
ZB
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D002051:Burkitt Lymphoma / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology*; D016481:Helicobacter Infections / Q000150:complications* / Q000473:pathology; D016480:Helicobacter pylori / Q000502:physiology*; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab